JLE

European Journal of Dermatology

MENU

Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia Volume 12, numéro 1, January - February 2002

Auteur
Merck Research Laboratories, 126 East Lincoln Avenue, RY33-500, Rahway, NJ 07065, USA.
  • Page(s) : 38-49
  • Année de parution : 2002

Androgenetic alopecia (male pattern hair loss, MPHL) occurs in men with an inherited sensitivity to the effects of androgens on scalp hair [1, 2]. The disorder is characterized by loss of visible hair over areas of the scalp due to progressive miniaturization of hair follicles [3-5]. MPHL does not occur in men with genetic deficiency of the Type 2 5alpha-reductase (5alphaR) enzyme, which converts testosterone (T) to dihydrotestosterone [...]